Close Menu

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

By signing up, you agree to the our terms and our Privacy Policy agreement.

What's Hot

South Korea to spend $1T on more memory chip production and humanoid robots

June 29, 2026

Refugees will be told to repay £10,000 under new asylum rules

June 29, 2026

Supreme Court Fed, FTC rulings impact on consumers

June 29, 2026

Facebook X (Twitter) Instagram

Addison Markets

Home
USA
Europe
Business
Investing
Tech
Politics
Contact Us

Addison Markets

Home»Investing»French biotech company Ipsen to buy Kartos Therapeutics for $450 million

Investing

French biotech company Ipsen to buy Kartos Therapeutics for $450 million

By franperez66q@protonmail.comJune 29, 2026No Comments1 Min Read

Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email

Facebook Twitter LinkedIn Pinterest Telegram Email

French biotech company Ipsen to buy Kartos Therapeutics for $450 million

Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

franperez66q@protonmail.com

Website

Honeywell Aerospace shares slip in Nasdaq debut

June 29, 2026

Digital Realty to buy Blackstone’s data center stake in deal valuing assets at $7.8 billion

June 29, 2026

NBCUniversal to be split from Comcast in latest media shakeup

June 29, 2026

Why is Nano Nuclear Energy stock rallying today?

June 29, 2026

Owens Corning shares jump on Carlisle bid report

June 29, 2026

Portugal stocks higher at close of trade; PSI up 0.26%

June 29, 2026

Top Reviews

South Korea to spend $1T on more memory chip production and humanoid robots

June 29, 2026

Refugees will be told to repay £10,000 under new asylum rules

June 29, 2026

Supreme Court Fed, FTC rulings impact on consumers

June 29, 2026

French biotech company Ipsen to buy Kartos Therapeutics for $450 million

June 29, 2026

Privacy Policy
Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.

Subscribe to Updates

What's Hot

French biotech company Ipsen to buy Kartos Therapeutics for $450 million

Related Posts